L. Rigoli et al., MITOCHONDRIAL-DNA STUDIES AND CLINICAL FINDINGS IN WOLFRAM-SYNDROME -AN ITALIAN MULTICENTER SURVEY, Diabetes, nutrition & metabolism, 11(2), 1998, pp. 114-120
The aim of this study was to verify the presence in Wolfram (DIDMOAD)
syndrome of some mitochondrial DNA abnormalities found by other Author
s either in this syndrome or in similar genetic syndromes and to evalu
ate the frequency of the main clinical features of the disease in an I
talian population. We abstracted and reviewed the medical records of 1
8 patients with at least two of the most salient Wolf ram syndrome cli
nical features, recruited from 10 Italian Centers. Mitochondrial DNA f
rom the patients' blood was examined for the 3243 tRNA-LEU point mutat
ion and for the 7.6 and 8.5 Kb deletions. Diabetes mellitus was the mo
st frequent clinical manifestation (100%), followed by optic atrophy (
89%), deafness (83%), diabetes insipidus (55%), urinary tract dilatati
on (50%) and primary hypogonadism (11%). Other less common clinical fe
atures were thiamine-responsive megaloblastic anemia and epilepsy. In
all cases we failed to detect the 3243 point mutation and the 7.6 and
8.5 Kb deletions. We conclude that : a) the 7.6 and 8.5 Kb mitochondri
al DNA deletions or the 3243 point mutation are not involved in the ae
tiology of Wolfram syndrome in our patients; b) the frequency of the f
our salient clinical features in this Italian population is very simil
ar to that recently reported by others in the United Kingdom; c) urina
ry tract abnormalities should be included among the typical clinical m
anifestations of this syndrome. Diab. Nutr. Metab. 11: 114-120, 1998.
(C) 1998, Editrice Kurtis.